The Kidney Function Tests Market is expected to register a CAGR of 6.1% during the forecast period. Kidney function tests are simple procedures that generally use either the blood or urine to help identify issues in the kidneys. There are a few different types of kidney function tests that investigate various aspects of kidney function. A kidney function test is performed to check if the kidneys are filtering waste products too slowly and to see if the kidneys are leaking proteins into the urine. Kidney function tests target either the urine or blood and measure different aspects of kidney function. Regular Kidney function tests may help in identify issues such as kidney disease in early stages, making it possible to halt the progress of the disease. Various types of kidney function tests are urine tests, blood tests, imaging tests, and kidney biopsy.

According to the National Kidney Foundation, about 1 in 3 adults in the United States are at risk for kidney disease, and many people with early forms of the disease have no symptoms. in addition, according to the Centre for Disease Control and Prevention, in the year 2017, about 44% of the diabetic patients in the United States suffered from End-Stage Renal Disease (ESRD) which increases the potential patients for kidney function test.

Increase in the alcohol consumption, incidences of hypertension, diabetes, and obesity, change to sedentary lifestyle and rising government initiatives for the awareness and treatment of kidney diseases are the key driving factors in kidney function tests market.

Key Market Trends

Dipstick Test Segment is Expected to Hold a Major Market Share in the Kidney Function Tests Market

A dipstick is a thin, plastic stick with strips of chemicals on it. The dipstick is dipped into the urine if strips color changes which indicate the presence of abnormalities such as excess amounts of protein, blood, pus, bacteria and sugar. This helps to detect a variety of kidney and urinary tract disorders such as chronic kidney disease, bladder infections, kidney stones and so on. As per University of California, San Francisco Report Statistics, estimates 2 million people globally suffer from End-Stage Renal Disease (ESRD), and the number of patients diagnosed with the kidney disease continues to increase at a rate of 5%-7% per year which increases the demand for kidney function test worlwide.

Dipstick Test segment hold a significant market share in the kidney function tests market and is anticipated to show similar trend over the forecast period due to cost-effectiveness, which also accounts for its widespread application across the globe. Globally, increasing incidences and prevalence of chronic kidney disease, increasing number of individuals suffering from diabetes which affects the kidney function and rising government initiatives for the awareness and treatment of kidney diseases are the key driving factors in the dipstick test segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the kidney function tests market due to rise in the geriatric population and prevalence of various kidney diagnosis incidents in this region. According to the Centers for Disease Control and Prevention, around 15% of United States adults in 37 million population are estimated to have chronic kidney disease during the year 2019. Furthermore 9 in every 10 adults with chronic kidney disease do not know they have it. In addition, increasing healthcare expenditure, technological advancements in diagnostic machinery and tools and presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Kidney Function Tests Market is fragmented in terms of competition and it consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are F.Hoffmann-La Roche Ltd, Danaher Corporation (Beckman Coulter, Inc), Siemens Healthineers, Cook Medical, C. R. Bard, Inc, Baxter International Inc, Abbott Laboratories, Nova Biomedical, Boston Scientific Corporation and Sysmex.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support